Mylan Launches First Adcirca Generic, Stock Moves Up

Mylan Launches First Adcirca Generic, Stock Moves Up

Source: 
Market Realist
snippet: 
Today, Mylan Pharmaceuticals (MYL) announced the launch of tadalafil tablets USP (20 mg) in the United States. Tadalafil is intended for the treatment of PAH (pulmonary arterial hypertension) for the improvement of exercise ability.